PDX PHARMACEUTICALS, LLC

Basic Information

24 INDEPENDENCE AVE
LAKE OSWEGO, OR, 97035-1401

Company Profile

n/a

Additional Details

Field Value
DUNS: 025852616
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: 3


  1. IGF::OT::IGF Novel siRNA-nanoparticle Platform for Treating Drug-Resistant HER2 Positive Breast Cancer

    Amount: $1,000,000.00

    Over one million women worldwide are diagnosed with breast cancer each year. Roughly 20% of all breast cancers overexpress the human epidennal growth receptor 2 (HER2-positive subtype). HER2-targeted ...

    SBIR Phase II 2014 Department of Health and Human Services
  2. PDX Pharmaceuticals

    Amount: $200,000.00

    Over one million women worldwide are diagnosed with breast cancer each year. Roughly 20% of all breast cancers overexpress the human epidennal growth receptor 2 (HER2-positive subtype). HER2-targeted ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. Iron functionalized silica as oral phosphate binder to treat hyperphosphatemia

    Amount: $299,741.00

    DESCRIPTION (provided by applicant): Hyperphosphatemia is universal to end stage chronic kidney disease patients and a majority of dialysis patients totaling of 400,000 in the US and 2 million worldwi ...

    STTR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government